Faeth Therapeutics, Inc
FTH
NASDAQ
Biotechnology
$32.34
USD
+3.79 (+13.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $737.74M
Volume 364.9K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 9.2 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 18.4 |
Operating Income | -18.4 |
EBITDA | -18.4 |
Other Income / Expense | 0.1 |
Total Other Income / Expense | 2.4 |
Income Before Income Taxes | -16.0 |
Income Taxes | 0.0 |
Net Income | -16.0 |
Consolidated Net Income / Loss | -16.0 |
Net Income Attributable to Common Shareholders | -16.0 |
Basic EPS | -$2.84 |
Diluted EPS | -$2.84 |
Basic Shares Outstanding | 5.6M |
Diluted Shares Outstanding | 5.6M |